Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 15,144 | 11,819 | 9,533 | 6,337 | 9,288 |
| Cost of Goods | 4,996 | 5,062 | 14,220 | 18,968 | 5,704 |
| Gross Profit | 10,148 | 6,757 | -4,687 | -12,631 | 3,584 |
| Operating Expenses | 34,994 | 29,929 | 29,440 | 30,163 | 27,921 |
| Operating Income | -23,850 | -23,110 | -33,907 | -41,826 | -23,633 |
| Other Income | -62,627 | 114 | 143 | 150 | -20,998 |
| Pre-tax Income | -86,477 | -22,996 | -33,764 | -41,676 | -44,631 |
| Income Tax | 20 | 20 | 20 | 20 | 20 |
| Net Income Continuous | -86,497 | -23,016 | -33,784 | -41,696 | -44,651 |
| Net Income | $-86,497 | $-23,016 | $-33,784 | $-41,696 | $-44,651 |
| EPS Basic Total Ops | -0.77 | -0.21 | -0.32 | -0.39 | -0.42 |
| EPS Basic Continuous Ops | -0.77 | -0.22 | -0.32 | -0.39 | -0.42 |
| EPS Diluted Total Ops | -0.77 | -0.21 | -0.32 | -0.39 | -0.42 |
| EPS Diluted Continuous Ops | -0.77 | -0.22 | -0.32 | -0.39 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.21 | -0.32 | -0.39 | -0.42 |
| EBITDA(a) | $39,285 | $-22,943 | $-33,738 | $-41,631 | $-4,957 |